FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:456-466 August 3, 2006 Number 5 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Editorial by Sperling, M. A. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background The ATP-sensitive potassium (K_ATP) channel, composed of the beta-cell proteins sulfonylurea receptor (SUR1) and inward-rectifying potassium channel subunit Kir6.2, is a key regulator of insulin release. It is inhibited by the binding of adenine nucleotides to subunit Kir6.2, which closes the channel, and activated by nucleotide binding or hydrolysis on SUR1, which opens the channel. The balance of these opposing actions determines the low open-channel probability, P_O, which controls the excitability of pancreatic beta cells. We hypothesized that activating mutations in ABCC8, which encodes SUR1, cause neonatal diabetes.

Methods We screened the 39 exons of ABCC8 in 34 patients with permanent or transient neonatal diabetes of unknown origin. We assayed the electrophysiologic activity of mutant and wild-type K_ATP channels.

Results We identified seven missense mutations in nine patients. Four mutations were familial and showed vertical transmission with neonatal and adult-onset diabetes; the remaining mutations were not transmitted and not found in more than 300 patients without diabetes or with early-onset diabetes of similar genetic background. Mutant channels in intact cells and in physiologic concentrations of magnesium ATP had a markedly higher P_O than did wild-type channels. These overactive channels remained sensitive to sulfonylurea, and treatment with sulfonylureas resulted in euglycemia.

Conclusions Dominant mutations in ABCC8 accounted for 12 percent of cases of neonatal diabetes in the study group. Diabetes results from a newly discovered mechanism whereby the basal magnesium-nucleotide–dependent stimulatory action of SUR1 on the Kir pore is elevated and blockade by sulfonylureas is preserved.

Source Information

From the Departments of Molecular and Cellular Biology (A.P.B., J.B.) and Medicine (L.A.-B.), Baylor College of Medicine, Houston; the Faculty of Medicine, René Descartes University, INSERM Unité 0363, Hôpital Necker Enfants Malades, Paris (M.P., K.B., R.S.); the Departments of Genetic Biochemistry (H.C.) and Pediatric Endocrinology (P.C.), Hôpital Robert Debré, Paris; Centre National de la Recherche Scientifique Unité 8090, the Pasteur Institute, Lille, France (M.V., P.F.); and the Department of Genomic Medicine, Imperial College London, Hammersmith Hospital, London (P.F.).

Drs. Babenko and Polak contributed equally to this article.

Address reprint requests to Dr. Polak at the Faculty of Medicine, René Descartes, Pediatric Endocrinology, INSERM Unité 0363, Hôpital Necker Enfants Malades, Paris, France, or at michel.polak{at}nck.aphp.fr.

Full Text of this Article

This article has been cited by other articles:

• Palmer, N. D., Langefeld, C. D., Bryer-Ash, M., Rotter, J. I., Taylor, K. D., Bowden, D. W. (2008). Association of the Kir6.2 E23K Variant with Reduced Acute Insulin Response in African-Americans. J. Clin. Endocrinol. Metab. 93: 4979-4983 [Abstract] [Full Text]  
• McCarthy, M. I., Hattersley, A. T. (2008). Learning From Molecular Genetics: Novel Insights Arising From the Definition of Genes for Monogenic and Type 2 Diabetes. Diabetes 57: 2889-2898 [Full Text]  
• Masia, R., Nichols, C. G. (2008). Functional Clustering of Mutations in the Dimer Interface of the Nucleotide Binding Folds of the Sulfonylurea Receptor. J. Biol. Chem. 283: 30322-30329 [Abstract] [Full Text]  
• Feng, Y., Mao, G., Ren, X., Xing, H., Tang, G., Li, Q., Li, X., Sun, L., Yang, J., Ma, W., Wang, X., Xu, X. (2008). Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients. Diabetes Care 31: 1939-1944 [Abstract] [Full Text]  
• Webster, N. J., Searle, G. J., Lam, P. P. L., Huang, Y.-C., Riedel, M. J., Harb, G., Gaisano, H. Y., Holt, A., Light, P. E. (2008). Elevation in Intracellular Long-Chain Acyl-Coenzyme A Esters Lead to Reduced {beta}-Cell Excitability via Activation of Adenosine 5'-Triphosphate-Sensitive Potassium Channels. Endocrinology 149: 3679-3687 [Abstract] [Full Text]  
• Abdulhadi-Atwan, M., Bushman, J. D., Tornovsky-Babaey, S., Perry, A., Abu-Libdeh, A., Glaser, B., Shyng, S.-L., Zangen, D. H. (2008). Novel De Novo Mutation in Sulfonylurea Receptor 1 Presenting as Hyperinsulinism in Infancy Followed by Overt Diabetes in Early Adolescence. Diabetes 57: 1935-1940 [Abstract] [Full Text]  
• Tarasov, A. I., Nicolson, T. J., Riveline, J.-P., Taneja, T. K., Baldwin, S. A., Baldwin, J. M., Charpentier, G., Gautier, J.-F., Froguel, P., Vaxillaire, M., Rutter, G. A. (2008). A Rare Mutation in ABCC8/SUR1 Leading to Altered ATP-Sensitive K+ Channel Activity and {beta}-Cell Glucose Sensing Is Associated With Type 2 Diabetes in Adults. Diabetes 57: 1595-1604 [Abstract] [Full Text]  
• Chen, R., Hussain, K., Al-Ali, M., Dattani, M. T., Hindmarsh, P., Jones, P. M., Marsh, P. (2008). Neonatal and Late-Onset Diabetes Mellitus Caused by Failure of Pancreatic Development: Report of 4 More Cases and a Review of the Literature. Pediatrics 121: e1541-e1547 [Abstract] [Full Text]  
• Aguilar-Bryan, L., Bryan, J. (2008). Neonatal Diabetes Mellitus. Endocr. Rev. 29: 265-291 [Abstract] [Full Text]  
• Lin, Y.-W., Bushman, J. D., Yan, F.-F., Haidar, S., MacMullen, C., Ganguly, A., Stanley, C. A., Shyng, S.-L. (2008). Destabilization of ATP-sensitive Potassium Channel Activity by Novel KCNJ11 Mutations Identified in Congenital Hyperinsulinism. J. Biol. Chem. 283: 9146-9156 [Abstract] [Full Text]  
• Babenko, A. P. (2008). A Novel ABCC8 (SUR1)-dependent Mechanism of Metabolism-Excitation Uncoupling. J. Biol. Chem. 283: 8778-8782 [Abstract] [Full Text]  
• Glaser, B. (2008). Insulin Mutations in Diabetes: The Clinical Spectrum. Diabetes 57: 799-800 [Full Text]  
• Edghill, E. L., Flanagan, S. E., Patch, A.-M., Boustred, C., Parrish, A., Shields, B., Shepherd, M. H., Hussain, K., Kapoor, R. R., Malecki, M., MacDonald, M. J., Stoy, J., Steiner, D. F., Philipson, L. H., Bell, G. I., the Neonatal Diabetes International Collaborative, , Hattersley, A. T., Ellard, S. (2008). Insulin Mutation Screening in 1,044 Patients With Diabetes: Mutations in the INS Gene Are a Common Cause of Neonatal Diabetes but a Rare Cause of Diabetes Diagnosed in Childhood or Adulthood. Diabetes 57: 1034-1042 [Abstract] [Full Text]  
• Polak, M., Dechaume, A., Cave, H., Nimri, R., Crosnier, H., Sulmont, V., de Kerdanet, M., Scharfmann, R., Lebenthal, Y., Froguel, P., Vaxillaire, M. (2008). Heterozygous Missense Mutations in the Insulin Gene Are Linked to Permanent Diabetes Appearing in the Neonatal Period or in Early Infancy: A Report From the French ND (Neonatal Diabetes) Study Group. Diabetes 57: 1115-1119 [Abstract] [Full Text]  
• Koster, J. C., Cadario, F., Peruzzi, C., Colombo, C., Nichols, C. G., Barbetti, F. (2008). The G53D Mutation in Kir6.2 (KCNJ11) Is Associated with Neonatal Diabetes and Motor Dysfunction in Adulthood that Is Improved with Sulfonylurea Therapy. J. Clin. Endocrinol. Metab. 93: 1054-1061 [Abstract] [Full Text]  
• Rafiq, M., Flanagan, S. E., Patch, A.-M., Shields, B. M., Ellard, S., Hattersley, A. T., The Neonatal Diabetes International Collaborative, (2008). Effective Treatment With Oral Sulfonylureas in Patients With Diabetes Due to Sulfonylurea Receptor 1 (SUR1) Mutations. Diabetes Care 31: 204-209 [Abstract] [Full Text]  
• Burke, M. A., Mutharasan, R. K., Ardehali, H. (2008). The Sulfonylurea Receptor, an Atypical ATP-Binding Cassette Protein, and Its Regulation of the KATP Channel. Circ. Res. 102: 164-176 [Abstract] [Full Text]  
• Shield, J. P.H., Flanagan, S. E., Mackay, D. J., Harries, L. W., Proks, P., Girard, C., Ashcroft, F. M., Temple, I. K., Ellard, S. (2008). Mosaic Paternal Uniparental Isodisomy and an ABCC8 Gene Mutation in a Patient With Permanent Neonatal Diabetes and Hemihypertrophy. Diabetes 57: 255-258 [Abstract] [Full Text]  
• de Wet, H., Rees, M. G., Shimomura, K., Aittoniemi, J., Patch, A.-M., Flanagan, S. E., Ellard, S., Hattersley, A. T., Sansom, M. S. P., Ashcroft, F. M. (2007). Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes. Proc. Natl. Acad. Sci. USA 104: 18988-18992 [Abstract] [Full Text]  
• Nichols, C. G. (2007). Alchemy in the Soup: Transforming Metabolic Signals to Excitability. Sci Signal 2007: pe59-pe59 [Abstract] [Full Text]  
• Polak, M. (2007). Neonatal Diabetes Mellitus: Insights for More Common Forms of Diabetes. J. Clin. Endocrinol. Metab. 92: 3774-3776 [Full Text]  
• Suzuki, S., Makita, Y., Mukai, T., Matsuo, K., Ueda, O., Fujieda, K. (2007). Molecular Basis of Neonatal Diabetes in Japanese Patients. J. Clin. Endocrinol. Metab. 92: 3979-3985 [Abstract] [Full Text]  
• Ashcroft, F. M. (2007). ATP-sensitive K+ channels and disease: from molecule to malady. Am. J. Physiol. Endocrinol. Metab. 293: E880-E889 [Abstract] [Full Text]  
• Shimomura, K., Horster, F., de Wet, H., Flanagan, S. E., Ellard, S., Hattersley, A. T., Wolf, N. I., Ashcroft, F., Ebinger, F. (2007). A novel mutation causing DEND syndrome: A treatable channelopathy of pancreas and brain. Neurology 69: 1342-1349 [Abstract] [Full Text]  
• Proks, P., Shimomura, K., Craig, T. J., Girard, C. A.J., Ashcroft, F. M. (2007). Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome. Hum Mol Genet 16: 2011-2019 [Abstract] [Full Text]  
• Flanagan, S. E., Patch, A.-M., Mackay, D. J.G., Edghill, E. L., Gloyn, A. L., Robinson, D., Shield, J. P.H., Temple, K., Ellard, S., Hattersley, A. T. (2007). Mutations in ATP-Sensitive K+ Channel Genes Cause Transient Neonatal Diabetes and Permanent Diabetes in Childhood or Adulthood. Diabetes 56: 1930-1937 [Abstract] [Full Text]  
• Tammaro, P., Ashcroft, F. (2007). The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits. J. Physiol. 581: 1259-1269 [Abstract] [Full Text]  
• Vaxillaire, M., Dechaume, A., Busiah, K., Cave, H., Pereira, S., Scharfmann, R., de Nanclares, G. P., Castano, L., Froguel, P., Polak, M., and the SUR1-Neonatal Diabetes Study Group, (2007). New ABCC8 Mutations in Relapsing Neonatal Diabetes and Clinical Features. Diabetes 56: 1737-1741 [Abstract] [Full Text]  
• Edghill, E. L., Gloyn, A. L., Goriely, A., Harries, L. W., Flanagan, S. E., Rankin, J., Hattersley, A. T., Ellard, S. (2007). Origin of de Novo KCNJ11 Mutations and Risk of Neonatal Diabetes for Subsequent Siblings. J. Clin. Endocrinol. Metab. 92: 1773-1777 [Abstract] [Full Text]  
• Codner, E., Flanagan, S. E., Ugarte, F., Garcia, H., Vidal, T., Ellard, S., Hattersley, A. T. (2007). Sulfonylurea Treatment in Young Children With Neonatal Diabetes: Dealing with hyperglycemia, hypoglycemia, and sick days. Diabetes Care 30: e28-e29 [Full Text]  
• Masia, R., De Leon, D. D., MacMullen, C., McKnight, H., Stanley, C. A., Nichols, C. G. (2007). A Mutation in the TMD0-L0 Region of Sulfonylurea Receptor-1 (L225P) Causes Permanent Neonatal Diabetes Mellitus (PNDM). Diabetes 56: 1357-1362 [Abstract] [Full Text]  
• Stanik, J., Gasperikova, D., Paskova, M., Barak, L., Javorkova, J., Jancova, E., Ciljakova, M., Hlava, P., Michalek, J., Flanagan, S. E., Pearson, E., Hattersley, A. T., Ellard, S., Klimes, I. (2007). Prevalence of Permanent Neonatal Diabetes in Slovakia and Successful Replacement of Insulin with Sulfonylurea Therapy in KCNJ11 and ABCC8 Mutation Carriers. J. Clin. Endocrinol. Metab. 92: 1276-1282 [Abstract] [Full Text]  
• Masia, R., Koster, J. C., Tumini, S., Chiarelli, F., Colombo, C., Nichols, C. G., Barbetti, F. (2007). An ATP-Binding Mutation (G334D) in KCNJ11 Is Associated With a Sulfonylurea-Insensitive Form of Developmental Delay, Epilepsy, and Neonatal Diabetes. Diabetes 56: 328-336 [Abstract] [Full Text]  
• Yamada, S., Kane, G. C., Behfar, A., Liu, X.-K., Dyer, R. B., Faustino, R. S., Miki, T., Seino, S., Terzic, A. (2006). Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J. Physiol. 577: 1053-1065 [Abstract] [Full Text]  
• (2006). Neonatal diabetes. EDUCATION AND PRACTICE 91: ep105-ep105 [Full Text]  
• Yan, F.-F., Casey, J., Shyng, S.-L. (2006). Sulfonylureas Correct Trafficking Defects of Disease-causing ATP-sensitive Potassium Channels by Binding to the Channel Complex. J. Biol. Chem. 281: 33403-33413 [Abstract] [Full Text]  
• Pearson, E. R., Flechtner, I., Njolstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., Slingerland, A. S., Shield, J., Robert, J.-J., Holst, J. J., Clark, P. M., Ellard, S., Sovik, O., Polak, M., Hattersley, A. T., the Neonatal Diabetes International Collaborative, (2006). Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.. NEJM 355: 467-477 [Abstract] [Full Text]  
• Sperling, M. A. (2006). ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.. NEJM 355: 507-510 [Full Text]